Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
MMP26 Biologics Sequence Review Report 2026: Matrix metalloproteinase-26 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of MMP26 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
MMP25 Biologics Sequence Review Report 2026: Matrix metalloproteinase-25 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of MMP25 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
MMP23B Biologics Sequence Review Report 2026: Matrix metalloproteinase-23 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of MMP23B protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
MMP21 Biologics Sequence Review Report 2026: Matrix metalloproteinase-21 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of MMP21 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
MMP20 Biologics Sequence Review Report 2026: Matrix metalloproteinase-20 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of MMP20 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
MMP19 Biologics Sequence Review Report 2026: Matrix metalloproteinase-19 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of MMP19 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
MMP14 Biologics Sequence Review Report 2026: Matrix metalloproteinase-14 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of MMP14 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
LRPAP1 Biologics Sequence Review Report 2026: Alpha-2-macroglobulin receptor-associated protein Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of LRPAP1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
LRP5L Biologics Sequence Review Report 2026: Low-density lipoprotein receptor-related protein 5-like protein Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of LRP5L protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
LRP11 Biologics Sequence Review Report 2026: Low-density lipoprotein receptor-related protein 11 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of LRP11 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
KLRG2 Biologics Sequence Review Report 2026: Killer cell lectin-like receptor subfamily G member 2 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of KLRG2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
KLRG1 Biologics Sequence Review Report 2026: Killer cell lectin-like receptor subfamily G member 1 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of KLRG1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
83
84
85
86
87
>>
1503
>